Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bramlage

Showing results (21-30 of 429) with videos related to

Pageof 43
Sort By:
Vascular Health and Risk Management|January 9, 2010
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utilityThomas Mengden, Sakir Uen, Peter Bramlage
Journal of Vascular Surgery|October 30, 2010
Treatment of peripheral arterial disease using stem and progenitor cell therapyHolger Lawall, Peter Bramlage, Berthold Amann
Blood Pressure Monitoring|July 8, 2016
Response to the letter to the Editor regarding 'Validation protocols for blood pressure-measuring devices: status quo and development needs' by Bruce AlpertBeate Beime, Cornelia Deutsch, Peter Bramlage
Medizinische Klinik (Munich, Germany : 1983)|February 3, 2006
[Antihypertensive drug utilization in obese patients]Peter Bramlage, Carsten Bramlage, Wilhelm Kirch
Diabetes & Metabolic Syndrome|December 18, 2016
Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose loweringHolger Fleischmann, Rüdiger Göke, Peter Bramlage
Vascular Health and Risk Management|November 22, 2013
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational studyJochen Seufert, Katrin Pegelow, Peter Bramlage
Journal of Cardiac Surgery|March 13, 2020
A four-leaf clover: A case report of quadricuspid aortic valve stenosisHenri Benkemoun, Peter Bramlage, Marc Beaufigeau
BMJ Open Diabetes Research & Care|October 24, 2019
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimenJochen Seufert, Anja Borck, Peter Bramlage
BMC Cardiovascular Disorders|November 13, 2008
Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary carePeter Bramlage, Eleonore Schönrock, Peter Odoj
BMC Cardiovascular Disorders|November 19, 2014
Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT)Peter Bramlage, Justus Strauch, Holger Schröfel
Pageof 43

Showing results (21-30 of 429) with videos related to

Sort By:
Pageof 43
Vascular Health and Risk Management|January 9, 2010
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utilityThomas Mengden, Sakir Uen, Peter Bramlage
Journal of Vascular Surgery|October 30, 2010
Treatment of peripheral arterial disease using stem and progenitor cell therapyHolger Lawall, Peter Bramlage, Berthold Amann
Blood Pressure Monitoring|July 8, 2016
Response to the letter to the Editor regarding 'Validation protocols for blood pressure-measuring devices: status quo and development needs' by Bruce AlpertBeate Beime, Cornelia Deutsch, Peter Bramlage
Medizinische Klinik (Munich, Germany : 1983)|February 3, 2006
[Antihypertensive drug utilization in obese patients]Peter Bramlage, Carsten Bramlage, Wilhelm Kirch
Diabetes & Metabolic Syndrome|December 18, 2016
Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose loweringHolger Fleischmann, Rüdiger Göke, Peter Bramlage
Vascular Health and Risk Management|November 22, 2013
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational studyJochen Seufert, Katrin Pegelow, Peter Bramlage
Journal of Cardiac Surgery|March 13, 2020
A four-leaf clover: A case report of quadricuspid aortic valve stenosisHenri Benkemoun, Peter Bramlage, Marc Beaufigeau
BMJ Open Diabetes Research & Care|October 24, 2019
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimenJochen Seufert, Anja Borck, Peter Bramlage
BMC Cardiovascular Disorders|November 13, 2008
Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary carePeter Bramlage, Eleonore Schönrock, Peter Odoj
BMC Cardiovascular Disorders|November 19, 2014
Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT)Peter Bramlage, Justus Strauch, Holger Schröfel
Pageof 43